Zeposia
Active substance: ozanimod
ozanimod hydrochloride
Centralised EU authorisationActive
Marketing holder: Bristol-Myers Squibb Pharma EEIG
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 2
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| US 3 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1209b-5816-76f7-b68b-c2c2cb67e86d,01a1209b-581b-76ad-bf5f-c8d124069be9,01a1209b-5825-7d1c-b254-a72788d0526a;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/004835
- Registration status
- Active
- ATC code
- L04AA38
Sources
- product · EMA · EMEA/H/C/004835 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/004835 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/004835 · Verified 2026-10-09